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Ethics: A Problem in Pharmacy?
Keith I. Yoshizuka, PharmD, MBA, JD, FCSHP

W

hat’s the big deal about ethics in pharmacy? Isn’t ethics simply the discipline dealing
with what is right and wrong and with moral duty and obligation?1 The American
Pharmacists Association even has its own Code of Ethics.2 The evidence suggests
that, on occasion, ethics is a problem with pharmacists. The June 2017 edition of the
California State Board of Pharmacy Newsletter, The Script, lists 27 pharmacists who
were subject to disciplinary action by the Board, and were required to take a course in
ethics within 60 calendar days of the hearing as a condition of keeping their license
to practice pharmacy.3 The requirements for such a course are codified in the California
Code of Regulations §1773.5.4 Isn’t ethics simply the discipline dealing with what is right
and wrong and with moral duty and obligation?5
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Contemporary biomedical ethics is largely based upon the model presented by
Beauchamp and Childress in 2001 known as the “Georgetown Mantra,” which is based on
four basic principles6:
• Beneficence
• Non-malfeasance
• Respect for autonomy
• Justice
Beneficence is the act of doing good, such as an act of kindness or charity. Derived from
the root word benefit, it means to bring or create benefit for others. It is altruism in its
purest sense. The corollary to bringing or creating benefit is to protect from harm or evil.
The ethical pharmacist has a duty to do good for the patient.
Non-malfeasance is the act of refraining from doing harm. Non-malfeasance is the foundation for the maxim found in the Hippocratic Oath, “first, do no harm,” or primum non
nocere.7 The underlying principle is to refrain from causing pain, suffering, or loss of life.
The pharmacist has an ethical duty not to leave the patient worse off than before the treatment. This ethical obligation has historically functioned as a barrier to physician-assisted
suicide but in furtherance of evolving societal concerns has been subordinated to other
ethical considerations for autonomy and justice discussed below (see also, California's End
of Life Options Act, Codified under Health and Safety Code §433 et seq.). An example of
this might be a terminally ill patient not expected to live beyond one year who will have to
endure pain and loss of dignity as he/she loses control of normal bodily functions. Such a
person may now choose to end his/her life to avoid the pain and humility until inevitable
demise. The patient has a right to choose to end his/her life with the assistance of health
professionals who may provide medications to accomplish this. This places the pharmacist
and other health care professionals in an ethical dilema as it creates a conflict between
ethical mandates: non-malfeasance versus the respect for autonomy.
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Respect for autonomy is to honor that the
patient has the right to choose for him
or herself according to the individual’s
beliefs and values. This principle not
only requires the professional to respect
the individual’s right to determine their
own course of therapy but to do so in
an informed fashion. It implies that
the patient receives full disclosure of
the potential benefits and risks of the
therapy. It is the foundation for the
concept of informed consent (besides
avoidance of the risk of being accused
of the tort of battery). The inference is
that in providing this disclosure, that the
pharmacist will also respect the privacy
and maintain the confidentiality of the
information on behalf of the patient.

1) pre-conventional morality, where decisions are made based on what is best
for them, with stage 1 consisting of
punishment avoidance and obedience
and stage 2 being exchange of favors;

Justice refers to the doctrine of fairness
and equitable treatment. It deals with the
equitable distribution of social benefits
and burdens. Theories of justice in
bioethics are divided into the theories of
utilitarian, egalitarian, and libertarian.8
All of the theories propose a system of
just distribution of benefits and burdens
equally without bias or preference. The
ethical pharmacist is duty bound to
allocate the benefits of drug therapy
in a just manner based on objective
criteria and not influenced by personal
preference or bias.

Again, this theory places moral development into “developmental categories”
but does not provide the practitioner
with any guidance to resolve an ethical
dilemma encountered in daily practice.
Ethical cognition can, however, differentiate between a good and a not-so-good
pharmacist and can help educators with
instilling educational values. This is of
value to academicians who are educating
pharmacy students before they become
practicing clinicians.

Others have divided the ethical principles
according to whom the duty relates to,
such as that owed to the consumer, the
community, the profession, the business,
and the wider healthcare team.9 Although
there is logic to identifying these duties
by stakeholder, the practitioner is left to
prioritize these duties on their own to
resolve an ethical dilemma.
Other academicians propose a psychological theory of cognitive moral
development (CMD), which is based
upon an individual’s progression through
various mental stages of moral development over time.10 Kohlberg identifies
three levels of moral development, with
two sub-stages within each level, as:

2) conventional morality, where decisions
are made to please others, especially
authority figures and persons with
higher status, with stage 3 seeking
positive feedback or compliments,
and stage 4 consisting of law and
order; and
3) post-conventional morality, where
decisions are made based upon
an abstract principle, with stage 5
reflecting a social contract, and stage 6
being universal ethical principle.11

These concepts seem basic enough for
pharmacists to follow, but the problems may arise when there are conflicts
between moral duty and obligations.
These moral dilemmas arise when two
or more conflicting issues arise out of
a single situation. An example might
be when a woman seeking to purchase
emergency contraception approaches
a pharmacist who subscribes to strict
Catholic beliefs regarding abortion and
contraception. The pharmacist is faced
with the ethical dilemma of pitting the
adherence to his religious beliefs versus
his duty to the woman as a patient who is
seeking him out as a health professional
for treatment. Sometimes these dilemmas
involve money. Pharmacists have long
been challenged between economic and
medical/professional motivations in
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their daily practice, because of the role of
the pharmacist as healthcare providers
and as business managers.12 One study
demonstrated that pharmacists are
aware of the ethical issues and possess
the practical skills required to resolve
the issues,13 and another study linked
community pharmacists’ moral reasoning
with clinical performance, showing that
pharmacists with a higher capacity for
moral reasoning demonstrated a higher
level of clinical performance.14 However,
it appears that the longer a pharmacist is
employed in a community setting, application of moral reasoning appears
to erode.15 This may be due in part to
the “commercialization” of healthcare,
and the conflicting obligations of duty
to the employer for profitability and
managing affordability with beneficence
and the other elements of
the “Georgetown Mantra.”12
Pharmacists are faced with ethical challenges daily in their practice.16 Sometimes
the question is not whether or not to
dispense but involves managing noncompliant patients.17 The pharmacist notices
that a man is noncompliant with his
antihypertensive medications. Upon
inquiry, the man admits that he stopped
taking the medication because of the erectile dysfunction side effect of the drug.
Although the pharmacist is bound by the
duty of beneficence, the pharmacist is
also bound by the obligation to respect
autonomy and self-determination. After
a detailed explanation of the consequences, it is ultimately up to the patient
to determine whether or not to continue
the treatment. Hospital pharmacists are
not exempt from these challenges and,
in fact, may be subjected to additional
challenges, such as being faced with
financial constraints or chronic drug
shortages.18 For example, at the time of
writing this paper, there is a national
shortage of sodium bicarbonate for injection. How is the determination made as to
which acidotic patients receive infusions
containing bicarbonate? Of course, the
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resolution must be determined by an
inter-professional group who develop
objective guidelines based on clinical
criteria, so that the allocation of the
scarce resources may be carried out fairly.
The issue of ethics in hospital pharmacy
practice is not isolated to the United
States; in 2014, there was a worldwide
pharmacy meeting to discuss the future of
hospital pharmacy practices and ethics.19
Of course, no discussion of ethics could
be complete in the 21st century without
a discussion of professional ethics as they
relate to social media. Individuals will
cite their rights of freedom of speech
based upon the first amendment of the
Constitution; however, the first amendment only prevents the government from
infringing speech. Even the government
as an employer can place restrictions as
a condition of employment.20 In the case
of McAuliffe v. Mayor of New Bedford, a
policeman was terminated from the job
for soliciting for political contributions,
a violation of police regulations. The
policeman initiated a lawsuit to be reinstated because the police regulation was
an infringement upon his right to free
speech, and political speech is among
the category of speech deserving the
most protection. The court ruled against
the policeman’s reinstatement, and in
his opinion, Justice Holmes stated, “The
petitioner may have a constitutional
right to talk politics, but he has no
constitutional right to be a policeman.”21
In this age of social media, it is tempting
to share frustrations at work with one’s
friends on social media. In doing this,
extreme care must be taken so as not
to violate HIPAA. Even if the identity
of the patient could not be discerned,
the employer would not be pleased
upon seeing one of their pharmacists
complaining about patients or making
fun of customers in a public forum. This
reflects poorly on the company, and
the employer could very convincingly
argue that such actions would dissuade

customers from using not only that
pharmacy but the entire pharmacy
chain. Some of the postings on social
media may run afoul of the ethical
principle of non-malfeasance by
doing harm to either the subject being
complained about or ridiculed or injury
to the reputation and standing in the
community of the employer.
Faced with these ethical dilemmas,
pharmacists and students alike often
seek one “right” answer. Therein lies a
significant challenge; there is no single
“right” answer. Between the good and
the bad, there lies an infinite number of
shades of gray.22

An ethical dilemma, by
definition, is the conflict
between two different
ethical principles which
are mutually exclusive.

An ethical dilemma, by definition, is the
conflict between two different ethical
principles which are mutually exclusive.
A decision made by an individual
practitioner may vary based upon that
individual’s personal beliefs, moral
conviction, and value systems. To make
the issue more complex, the goals and
priorities of employers may conflict
with the individual practitioner’s values.
Society provides us with some guidance
by way of passing laws and regulations
to facilitate in our decision-making
when faced with these conflicts.23 One
such example is California Business &
Professions Code §733(b)(3), which
provides the procedures to be followed
if a pharmacist refuses to fill an order or
prescription based on ethical, moral, or
religious grounds.24 However, laws and
regulations will not cover all the ethical
dilemmas encountered by the pharmacist
in his/her daily practice.
One strategy to develop ethics awareness
and skills in practitioners is to provide
additional training. The California State
Board of Pharmacy adopted a new
regulation to require that a portion of
the mandatory continuing education
hours required for licensure renewal be
carved out such that two hours involve
a course in ethics and pharmacy law.
This is not unusual, as a portion of the
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continuing education hours for attorneys in California has always included
mandatory training in ethics, substance
abuse, and elimination of bias for
licensure renewal. Given the trend in
accreditation of schools and colleges for
the health professions, it would not be
unreasonable to have these programs
offered in an inter-professional format.25
Professionals from different disciplines
facing the same ethical challenge from
different perspectives are reflective of
what occurs in real life, so it makes sense
that training in ethics should also occur
in an inter-professional venue. With
additional training, pharmacists should
be able to navigate the challenges of
ethical dilemmas encountered in practice
by being able to identify and categorize
the issues that they are facing, and then

arrive at a rational conclusion based upon
prioritization of ethical principles.26
In conclusion, it appears that ethics, or
the lack or attenuation thereof, is an
important issue facing practicing pharmacists today. There are both statutory
and regulatory provisions to support the
requirement of ongoing education and
training in ethics. Evidence of formal
disciplinary actions by the California State
Board of Pharmacy faced requiring pharmacists to take a formal course in ethics
as a condition of retention of licensure is
sufficient to demonstrate that pharmacists are deviating from the expectations
consistent with ethical behavior. Periodic
review of the principles of beneficence,
non-malfeasance, autonomy, and justice
would benefit pharmacists in practice,

as evidence infers that a pharmacist’s
moral reasoning erodes with time.
Additional training in ethics may be
beneficial to the practicing pharmacist,
particularly since there is evidence
to support that pharmacists with a
higher capacity for moral reasoning
demonstrated a higher level of clinical
performance. Faced with professionals
committing ethical breaches compromising their license and the dilemmas
created by the commercialization of
healthcare, the California State Board of
Pharmacy is warranted in their requirement that a portion of the 30 hours
of continuing education required for
continued licensure be grounded in the
training of ethics. o
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